About LabCyte
LabCyte is a company based in Sunnyvale (United States) founded in 2000 was acquired by Beckman Coulter in January 2019. LabCyte has raised $33.39 million across 8 funding rounds from investors including SVB, Beckman Coulter and Credit Suisse. The company has 184 employees. LabCyte has completed 1 acquisition, including Deerac Fluidics. LabCyte operates in a competitive market with competitors including Opentrons, Tecan, Andrew Alliance, Scienion and Flow Robotics, among others.
- Headquarter Sunnyvale, United States
- Employees 184
- SectorsHealthcare
- Website labcyte.com
- Social LinkedIn X
- Acquired by Beckman Coulter (Jan 2019)
- Legal Name Labcyte Inc.
- Total Equity Funding$33.39M (USD)
in 8 rounds
- Latest Funding Round$5M (USD), Series D
Jan 2017
- InvestorsSVB
& 13 more
- Employee Count184
- Investments & Acquisitions
- Acquired byBeckman Coulter
(Jan 2019)
Funding Insights of LabCyte
LabCyte has successfully raised a total of $33.39M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $5 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $33.39M
- Total Rounds 8
- Last Round Series D — $5M
- First Round $1.6M
(Feb 2002)
- Investors Count 13
All 8 funding rounds of LabCyte with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $5M | Series D | – | – | – |
| May 2015 | $17M | Debt – Conventional | – | – | |
| Nov 2013 | $1M | Grant | – | – | |
| Sep 2013 | $5.79M | Series D | – | General Electric | |
| Nov 2011 | $196,000 | Grant | – | – | |
| Aug 2010 | – | Grant | – | – | |
| Jul 2005 | $21M | Series C | – | – | |
| Feb 2002 | $1.6M | Seed | – | – | – |
14 investors in total: 14 institutional.
Investors in LabCyte
LabCyte has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Beckman Coulter and Credit Suisse.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Early stage venture capital firm investing in US | 1973 | abingworth.com | London, United Kingdom | |
Early stage venture capital firm investing in the US | – | alloyventures.com | Palo Alto, United States | |
- | – | crossatlanticpartners.com | - | |
Investments are made in life sciences firms across all stages. | – | delphiventures.com | Menlo Park, United States | |
Investments are made in early to mid-stage US companies. | – | xacp.com | Radnor, United States | |
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States | |
Cancer research is conducted and supported by the institute. | – | cancer.gov | Bethesda, United States | |
Diversified operations are conducted across multiple industries worldwide. | 1892 | ge.com | United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States |
Investor details for LabCyte
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LabCyte
12 people are tracked at LabCyte (2 in leadership, 10 in team); the tracked headcount is 184.
| Name | Role | Group |
|---|---|---|
Mark Bramwell | Director of Worldwide Support | Leadership |
Brent Browning | Sr. Director of Engineering | Leadership |
Bill McClintock | Senior Staff Engineer / Manager | Team |
Elena Pletneva | Sr. SQA Engineer | Team |
Stephen Hinkson | System Engineer | Team |
Lisa Jungherr | Research Engineer | Team |
Kevin Piedad | Software Engineer | Team |
Alex Sakhanyuk | Sr. Release Engineer | Team |
Ric Piedad | Sr Mechanical Engineer | Team |
Michael Travis | Asia Pacific Support Regional Manager | Team |
Andreas Kadavanich | Staff Systems Engineer | Team |
Zach Smith | Software Engineer | Team |
Complete people profiles for LabCyte
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LabCyte
LabCyte has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Deerac Fluidics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Fluidic systems are engineered for scientific and research applications. | deerac.com | Cambridge, United States | 2003 | Jan 2008 | •••• |
Complete acquisition details for LabCyte
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of LabCyte
5 dated milestones of LabCyte across 19 years, from founding to its latest funding, stage changes and deals.
- Founded LabCyte is founded.
- Funding First funding round of $1.6M.
- Acquisition Acquires Deerac Fluidics.
- Funding Latest funding round, Series D, of $5.0M.
- Exit Acquired by Beckman Coulter.
Competitors of LabCyte
LabCyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Opentrons, Tecan, Andrew Alliance, Scienion and Flow Robotics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| opentrons.com | 2013 | Brooklyn, United States | $240.56M | 177 | Pipetting robots for laboratory automation are developed. | |
| tecan.com | 1980 | Mannedorf, Switzerland | – | – | Automated laboratory instruments, robotics, and diagnostic solutions are provided. | |
| andrewalliance.com | 2011 | Vernier, Switzerland | $14.03M | 5 | Provider of automated liquid handling tools and software for scientific labs | |
| scienion.com | 2000 | Berlin, Germany | $5.67M | 114 | Non-contact dispensing solutions for genomics and proteomics are provided. | |
| flow-robotics.com | 2015 | Copenhagen, Denmark | $17.15M | 16 | AI-based robots for laboratory liquid handling automation are provided. | |
| ginolis.com | 2010 | Oulunsalo, Finland | $2.41M | – | Liquid handling and lab automation robots | |
| seedbiosciences.com | 2018 | Renens, Switzerland | $1.53M | – | Programmable robotic liquid handling systems for cell isolation are developed. | |
| avidien.com | 2009 | Hudson, United States | $4M | – | Automated liquid handling systems are developed for research labs. | |
| alphasip.es | 2008 | Zaragoza, Spain | – | – | Nanotube-based biosensor chips are produced for real-time medical diagnostics. |
Detailed competitors of LabCyte
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of LabCyte
Websites that share an audience with LabCyte (labcyte.com).
Websites whose visitors overlap most with LabCyte. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genedata.com | 100% | 36.5K | #383,117 | View details | |
hamptonresearch.com | hamptonresearch.com | 94% | – | #1,884,073 | – |
| tecan.com | 82% | 86.6K | #416,898 | View details | |
esd.ornl.gov | esd.ornl.gov | 64% | – | – | – |
| peptide.com | 64% | – | #428,559 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for LabCyte
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Labcyte
Complete news archive for LabCyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to LabCyte
10 companies that operate in the same segment as LabCyte (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LabCyte
LabCyte was founded in 2000 and raised its 1st funding round 2 years after it was founded.
LabCyte is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
LabCyte is a funded company, having raised a total of $33.39M across 8 funding rounds to date. The company's 1st funding round was a Seed of $1.6M, raised on Feb 2002.
LabCyte has 184 employees.
LabCyte is a developer of acoustic liquid handling for life science research. Its products use acoustic energy to transfer precise amounts of fluids without touching them. This capability improves data quality and reliability, while eliminating or substantially reducing costs associated with pipette tips, reagents and waste disposal. Also, it conserves precious samples and enables highly accurate assay miniaturization, dramatically improving productivity. Labcyte products offers solutions for: High throughput and secondary screening, Cell-based and biochemical assays and ADME-Tox, Genomics Next-Gen sequencing, RT-qPCR and genotyping Proteomics-Proteinpeptide arrays, biomarkers, and protein crystallography.
LabCyte's top competitors include Opentrons, Tecan and Andrew Alliance.
LabCyte has made 1 acquisition, including Deerac Fluidics.
LabCyte has 14 investors. Key investors include SVB, Beckman Coulter, Credit Suisse, NIH, and General Electric.
LabCyte operates through Labcyte Inc..
Yes. LabCyte was acquired by Beckman Coulter in January 2019.